Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  vinflunine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA183-002, NCT00389155
Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: L0070 IN 302 P1, CA183004, NCT00315237
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: L00070 IN 308 B0, NCT01091168
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: L00070 IN 305 B0, 2008-004171-21, NCT01095003
Pazopanib and Vinflunine in Urothelial Cancer of the Bladder
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DZITM1, NCT01265940
Phase II Study of Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium That Relapsed or Progressed After Prior Platinum-Based Chemotherapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BMS-CA183001, UPCC-07804, NCT00101608
A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: I-05-009, NCT00251446
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI LUN 122, NCT00284154
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI BRE 89, NCT00284180
Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000536545, NCCTG-N0632, N0632, NCT00450515
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI GU 35, NCT00545766
Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: SOGUG2011/02, NCT01529411
JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: L00070 IN 213 P1, NCT01599013
A Study of the Alternative Administration of Ixabepilone and Vinflunine
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA183-008, NCT00362830
Effect of Ketoconazole on the Pharmacokinetics of Vinflunine
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA183-009, NCT00388557
Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: LCCC 0509, CDR0000550148, UNC-LCCC-0509, LCC 0506, NCT00320073
JAVLOR® Online Non-Interventional Trial
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: JONAS-1, NCT01103544
Start Over